Stay updated on Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial

Sign up to get notified when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The clinical trial record for the nintedanib study is available with its study details, results-related information, participating locations, and supporting documents. It also includes information about individual participant data sharing.
    Difference
    82%
    Check dated 2026-11-09T13:40:48.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:30:07.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website changes and links to transition updates and FAQs, noting that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-26T14:49:23.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2. The study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:39:22.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:44:26.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The 403 error block was removed, allowing the page to display the study details rather than an error page.
    Difference
    0.5%
    Check dated 2026-09-28T17:32:09.000Z thumbnail image

Stay in the know with updates to Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.